-
Why Need to Watch: Actinium Pharmaceuticals (NYSEMKT:ATNM), Kinder Morgan (NYSE:KMI), Colfax Corporation (NYSE:CFX), Starbucks Corporation (NASDAQ:SBUX), E-House (China) Holdings (NYSE:EJ)
On Monday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.42. On May 13, Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM), announced the appointment of Jeng-Dar Yang, Ph.D. to the position of Vice President of Pharmaceutical Development effective May 4, 2015. Dr. Yang brings with him 23 years of biotechnology experience in increasingly senior roles. Kinder Morgan, Inc. […]
-
Traders Are Watching: Weatherford International (NYSE:WFT), Contango Oil & Gas (NYSEMKT:MCF), UDR (NYSE:UDR), Fidelity National Information Services (NYSE:FIS), Actinium Pharmaceuticals (NYSEMKT:ATNM)
On Wednesday shares of Weatherford International plc (NYSE:WFT) closed at $14.35. Company’s sales growth for last 5 years was 11.00% and EPS growth for next 5 years is recorded as -1.50%. On 5 May, Weatherford International plc (NYSE:WFT) announced the commercial release of its SecureView® wireline cased-hole evaluation suite at the 2015 Offshore Technology Conference […]
-
Worth Watching Stocks: Actinium Pharmaceuticals (NYSEMKT:ATNM), First Solar (NASDAQ:FSLR), Parker Drilling Co. (NYSE:PKD), Avis Budget Group (NASDAQ:CAR)
On Friday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.52. On April 29, Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) will be a sponsor of the upcoming 9th Symposium on Targeted Alpha Therapy, to be held in Warsaw, Poland on May 19-21. The symposium is jointly organized by the Institute for Transuranium Elements of the European Commission, […]
-
Today’s Watch List: Actinium (NYSEMKT:ATNM), Starbucks (NASDAQ:SBUX), Liberty Property Trust (NYSE:LPT), American Water Works (NYSE:AWK), E. I. du Pont de Nemours (NYSE:DD)
On Thursday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.52. On April 22, Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) said it is partnering with the Aplastic Anemia & MDS International Foundation, a leading non-profit health organization, to present educational forums to patients and their families on bone marrow transplant, MDS, aplastic anemia and PNH. Starbucks Corporation […]
-
Eye Catching Stocks: The Goodyear Tire & Rubber Company (NASDAQ:GT), ImmunoGen (NASDAQ:IMGN), Actinium Pharmaceuticals (NYSEMKT:ATNM), Nokia (NYSE:NOK), Ford Motor (NYSE:F)
On Wednesday shares of The Goodyear Tire & Rubber Company (NASDAQ:GT) closed at $28.34. Company’s sales growth for last 5 years was 2.20% and EPS growth for next 5 years is recorded as 11.00%. The Goodyear Tire & Rubber Co. (NASDAQ:GT) on Wednesday reported first-quarter net income of $224 million, after reporting a loss in […]
-
Hot Stocks: Actinium Pharmaceuticals (NYSEMKT:ATNM), RADA Electronic Industries (NASDAQ:RADA), Praxair Inc. (NYSE:PX), Vedanta Limited (NYSE:SSLT), StarTek (NYSE:SRT)
On Monday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.80. On 24 March, Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) announced that the Company is moving forward with enrollment and treatment of additional patients in its clinical trial for acute myeloid leukemia (AML) in patients over the age of 60. RADA Electronic Industries Ltd. (NASDAQ:RADA) in last […]
-
Worth Watching Stocks: Actinium Pharmaceuticals (NYSEMKT:ATNM), CorMedix (NYSEMKT:CRMD), The Hershey Company (NYSE:HSY), CME Group Inc. (NASDAQ:CME), The First Bancshares (NASDAQ:FBMS)
On Wednesday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.87. Actinium Pharma (NYSEMKT:ATNM) announced that the Company is moving forward with enrollment and treatment of additional patients in its clinical trial for acute myeloid leukemia (AML) in patients over the age of 60. CorMedix, Inc. (NYSEMKT:CRMD) in last trading activity remains unchanged to close […]
-
Hot Watch List: Actinium Pharmaceuticals (NYSEMKT:ATNM), Jones Energy (NYSE:JONE), Hibbett Sports (NASDAQ:HIBB), Capital Product Partners (NASDAQ:CPLP), Paragon Shipping (NASDAQ:PRGN)
On Friday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.87. On March 18, Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM), announced the completion of the third cohort of the Company’s ongoing multi-center Phase 1/2 Study for Actimab-A for the treatment of newly diagnosed Acute Myeloid Leukemia (AML) in elderly patients. Cohort 3, which included 3 additional patients, […]
-
Top News: Calithera Biosciences (NASDAQ:CALA), Actinium Pharmaceuticals (NYSEMKT:ATNM), Vodafone Group Plc (ADR) (NASDAQ:VOD), Urban Outfitters (NASDAQ:URBN), The Boeing Company (NYSE:BA)
On Thursday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $14.07. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA) announced the upcoming presentation of five preclinical abstracts, highlighting the potential of CB-839, the Company’s novel, orally bioavailable glutaminase inhibitor, at the American Association for Cancer Research, taking place […]
-
Don’t Miss These Stocks: Penn West Petroleum (NYSE:PWE), Actinium Pharmaceuticals (NYSEMKT:ATNM), The Madison Square Garden (NASDAQ:MSG), CombiMatrix NASDAQ:CBMX), Stein Mart (NASDAQ:SMRT)
A freshly renegotiated deal with lenders and a second dividend cut in three months have given Penn West Petroleum Ltd. (NYSE:PWE) a small cushion as it struggles under a hefty layer of debt and low oil prices. The energy firm said Thursday it lost $1.77-billion in the fourth quarter and $1.733-billion for all of 2014, […]